Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 105

Similar articles for PubMed (Select 23352314)

1.

Expression of alpha 1,6-fucosyltransferase 8 in hepatitis B virus-related hepatocellular carcinoma influences tumour progression.

Ji J, Gu X, Fang M, Zhao Y, Yi C, Wang A, Gao C.

Dig Liver Dis. 2013 May;45(5):414-21. doi: 10.1016/j.dld.2012.12.007. Epub 2013 Jan 24.

PMID:
23352314
2.

Downregulation of microRNA-15b by hepatitis B virus X enhances hepatocellular carcinoma proliferation via fucosyltransferase 2-induced Globo H expression.

Wu CS, Yen CJ, Chou RH, Chen JN, Huang WC, Wu CY, Yu YL.

Int J Cancer. 2014 Apr 1;134(7):1638-47. doi: 10.1002/ijc.28501. Epub 2013 Oct 15.

PMID:
24122375
3.

[The expression of hepatitis B virus X protein and cyclooxygenase-2 in hepatitis B virus-related hepatocellular carcinoma: correlation with microangiogenesis and metastasis, and what is the possible mechanism].

Liu KG, Shao XL, Xie HH, Xu L, Zhao H, Guo ZH, Li L, Liu J.

Zhonghua Gan Zang Bing Za Zhi. 2010 Nov;18(11):831-6. doi: 10.3760/cma.j.issn.1007-3418.2010.11.010. Chinese.

PMID:
21138631
4.

P21WAF1/CIP1 messenger RNA expression in hepatitis B, C virus-infected human hepatocellular carcinoma tissues.

Kobayashi S, Matsushita K, Saigo K, Urashima T, Asano T, Hayashi H, Ochiai T.

Cancer. 2001 Jun 1;91(11):2096-103.

PMID:
11391590
5.

Liver-intestine cadherin predicts microvascular invasion and poor prognosis of hepatitis B virus-positive hepatocellular carcinoma.

Ding ZB, Shi YH, Zhou J, Shi GM, Ke AW, Qiu SJ, Wang XY, Dai Z, Xu Y, Fan J.

Cancer. 2009 Oct 15;115(20):4753-65. doi: 10.1002/cncr.24513.

6.

Epigenetic repression of miR-132 expression by the hepatitis B virus x protein in hepatitis B virus-related hepatocellular carcinoma.

Wei X, Tan C, Tang C, Ren G, Xiang T, Qiu Z, Liu R, Wu Z.

Cell Signal. 2013 May;25(5):1037-43. doi: 10.1016/j.cellsig.2013.01.019. Epub 2013 Jan 30.

PMID:
23376496
7.

Expression of bile duct-type cytokeratin in noncancerous hepatocytes in patients with hepatitis B virus-related hepatocellular carcinoma.

Uenishi T, Kubo S, Hirohashi K, Yamamoto T, Ogawa M, Tanaka H, Shuto T, Kinoshita H.

Hepatogastroenterology. 2003 Jul-Aug;50(52):1101-4.

PMID:
12845990
8.

Differential promoter usage for insulin-like growth factor-II gene in Chinese hepatocellular carcinoma with hepatitis B virus infection.

Tang SH, Yang DH, Huang W, Zhou M, Zhou HK, Lu XH, Ye G.

Cancer Detect Prev. 2006;30(2):192-203. Epub 2006 May 12.

PMID:
16697535
9.

Changes in glucose-6-phosphate dehydrogenase expression results in altered behavior of HBV-associated liver cancer cells.

Hu H, Ding X, Yang Y, Zhang H, Li H, Tong S, An X, Zhong Q, Liu X, Ma L, Liu Q, Liu B, Lu Z, Zhang D, Hu P, Ren H.

Am J Physiol Gastrointest Liver Physiol. 2014 Sep 15;307(6):G611-22. doi: 10.1152/ajpgi.00160.2014. Epub 2014 Jul 3.

PMID:
24994855
10.

SiRNA-targeted carboxypeptidase D inhibits hepatocellular carcinoma growth.

Jin T, Fu J, Feng XJ, Wang SM, Huang X, Zhu MH, Zhang SH.

Cell Biol Int. 2013 Sep;37(9):929-39. doi: 10.1002/cbin.10113. Epub 2013 Apr 30.

PMID:
23589395
11.

Reduction of double-stranded RNA-activated protein kinase in hepatocellular carcinoma associated with hepatitis B virus.

Chen GG, Lai PB, Ho RL, Chan PK, Xu H, Wong J, Lau WY.

J Med Virol. 2004 Jun;73(2):187-94.

PMID:
15122791
12.

Upregulated FoxM1 expression induced by hepatitis B virus X protein promotes tumor metastasis and indicates poor prognosis in hepatitis B virus-related hepatocellular carcinoma.

Xia L, Huang W, Tian D, Zhu H, Zhang Y, Hu H, Fan D, Nie Y, Wu K.

J Hepatol. 2012 Sep;57(3):600-12. doi: 10.1016/j.jhep.2012.04.020. Epub 2012 May 18.

PMID:
22613004
13.
15.

Wnt-1 protein as a prognostic biomarker for hepatitis B-related and hepatitis C-related hepatocellular carcinoma after surgery.

Lee HH, Uen YH, Tian YF, Sun CS, Sheu MJ, Kuo HT, Koay LB, Lin CY, Tzeng CC, Cheng CJ, Tang LY, Tsai SL, Wang AH.

Cancer Epidemiol Biomarkers Prev. 2009 May;18(5):1562-9. doi: 10.1158/1055-9965.EPI-09-0039.

16.

[Expression of caveolin-1 gene in hepatitis B-related hepatocellular carcinoma and the clinical significance thereof].

Yan J, Lu Q, Cai L, Li XW, Dong JH.

Zhonghua Yi Xue Za Zhi. 2008 Dec 16;88(46):3272-4. Chinese.

PMID:
19159553
17.

Detection of HBV genotypes of tumor tissues and serum by a fluorescence polarization assay in north-western China's hepatocellular carcinoma patients.

Lu J, Gong W, Cheng H, Wu Z, Li D, Wang X, Liang P, Zhang J.

Virol J. 2011 Jul 22;8:362. doi: 10.1186/1743-422X-8-362.

18.

Relationship between elevated FX expression and increased production of GDP-L-fucose, a common donor substrate for fucosylation in human hepatocellular carcinoma and hepatoma cell lines.

Noda K, Miyoshi E, Gu J, Gao CX, Nakahara S, Kitada T, Honke K, Suzuki K, Yoshihara H, Yoshikawa K, Kawano K, Tonetti M, Kasahara A, Hori M, Hayashi N, Taniguchi N.

Cancer Res. 2003 Oct 1;63(19):6282-9.

19.

Comparison of clinical features and survival in patients with hepatitis B and C virus-related hepatocellular carcinoma.

Tanizaki H, Ryu M, Kinoshita T, Kawano N, Konishi M, Cho A, Nakatsura T, Natsume T, Takahashi S, Sugita M, Izuishi K, Yoshino M, Furuse J, Iwasaki M, Tsubono Y.

Jpn J Clin Oncol. 1997 Apr;27(2):67-70.

20.

Allele loss and down-regulation of heparanase gene are associated with the progression and poor prognosis of hepatocellular carcinoma.

Huang GL, Li BK, Zhang MY, Wei RR, Yuan YF, Shi M, Chen XQ, Huang L, Zhang HZ, Liu W, Huang BJ, Li H, Zheng XF, Luo XR, Wang HY.

PLoS One. 2012;7(8):e44061. doi: 10.1371/journal.pone.0044061. Epub 2012 Aug 31.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk